Filter

Refine by collections

  • Growth Hormone in Endocrine Cancers (2)

Refine by date

—

Refine by access

  • Print
  • Save

Search Results

You are looking at 1 - 2 of 2 items for :

  • "high-grade" x
  • Growth Hormone in Endocrine Cancers x
  • Refine by access: All content x
Clear All
Reetobrata Basu Edison Biotechnology Institute, Athens, Ohio, USA

Search for other papers by Reetobrata Basu in
Google Scholar
PubMed Close
and
John J Kopchick Edison Biotechnology Institute, Athens, Ohio, USA
Molecular and Cellular Biology Program, Ohio University, Athens, Ohio, USA
Heritage College of Osteopathic Medicine, Ohio University, Athens, Ohio, USA

Search for other papers by John J Kopchick in
Google Scholar
PubMed Close

tract cancers ( Riesterer et al. 2011 ), nasopharyngeal carcinoma ( Wang et al. 2019 ), osteosarcoma ( Wang et al. 2009 ) and pediatric high-grade glioma ( Simpson et al. 2020 ). Therefore, GH and IGF1 are strongly implicated as a major

Article Type:
Review Article
Collections:
Growth Hormone in Endocrine Cancers
DOI:
https://doi.org/10.1530/ERC-22-0414
Volume/Issue:
Volume 30: Issue 9
Free access
Cesar Luiz Boguszewski Department of Internal Medicine, Endocrine Division (SEMPR), University Hospital, Federal University of Parana, Curitiba, Brazil

Search for other papers by Cesar Luiz Boguszewski in
Google Scholar
PubMed Close
,
Margaret Cristina da Silva Boguszewski Department of Pediatrics, Endocrine Division (SEMPR), University Hospital, Federal University of Parana, Curitiba, Brazil

Search for other papers by Margaret Cristina da Silva Boguszewski in
Google Scholar
PubMed Close
, and
Wouter W de Herder Department of Internal Medicine, Sector of Endocrinology, Erasmus Medical Center, Rotterdam, The Netherlands

Search for other papers by Wouter W de Herder in
Google Scholar
PubMed Close

(EPIC) study involving 141,896 men showed that those who were taller had an elevated risk of high-grade prostate cancer and prostate cancer death ( Perez-Cornago et al. 2017 ). In more recent years, the Mendelian randomization (MR) approach was

Article Type:
Review Article
Collections:
Growth Hormone in Endocrine Cancers
DOI:
https://doi.org/10.1530/ERC-22-0400
Volume/Issue:
Volume 30: Issue 4
Free access